SCHEMBL5358773

SCHEMBL5358773

COC(=O)C(Cc1cccc(OCC(=O)O)c1)OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.55
PPARA Q07869 3/20 0.52
PPARG P37231 2/20 0.52
FFAR1 O14842 1/20 0.46
PKM P14618 1/20 0.45
HTT P42858 1/20 0.45
ALOX15 P16050 1/20 0.45
MAPK1 P28482 1/20 0.44
GAA P10253 1/20 0.43
PTGIR P43119 2/20 0.43
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
CA9 Q16790 1/20 0.43
PPARD Q03181 1/20 0.42
PTGDR2 Q9Y5Y4 2/20 0.42
PTPN7 P35236 1/20 0.42
MEN1 O00255 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5364045 0.87 EPOR (0.54) PPARAPPARGFFAR1MEN1KMT2A
SCHEMBL5357749 0.84 ITGB1 (0.43) LMNAPPARAPPARGGAAPPARD
SCHEMBL5028808 0.83 PPARA (0.51) LMNAPPARAPPARGALOX15MAPK1
SCHEMBL5028810 0.83 PPARA (0.51) LMNAPPARAPPARGALOX15MAPK1
SCHEMBL14285180 0.83 PPARA (0.51) LMNAPPARAPPARGALOX15MAPK1
SCHEMBL14366607 0.83 MAPK1 (0.44) PPARAPPARGMAPK1GAAPPARD
SCHEMBL5383333 0.83 MAPK1 (0.44) PPARAPPARGMAPK1GAAPPARD
SCHEMBL5375724 0.82 PPARG (0.46) PPARAPPARGMAPK1GAAPPARD
SCHEMBL6151259 0.82 PTPN1 (0.43) PPARAPPARGFFAR1PPARDALDH1A1
SCHEMBL10202711 0.80 PPARA (0.59) LMNAPPARAPPARGFFAR1ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7220880-B2 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2007-05-22 US disclosed
US-7220880-B2 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2007-05-22 US disclosed
US-7220880-B2 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2007-05-22 US disclosed
US-20060111406-A1 Amide linker peroxisome proliferator activated receptor modulators ELI LILLY AND COMPANY (US) 2006-05-25 US disclosed
EP-1517882-A1 AMIDE LINKER PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2005-03-30 EP disclosed
WO-2004000789-A9 AMIDE LINKER PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS LILLY CO ELI (US) 2004-03-11 WO disclosed
WO-2004000789-A1 AMIDE LINKER PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR MODULATORS ELI LILLY AND COMPANY (US) 2003-12-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060111406-A1 Amide linker peroxisome proliferator activated receptor modulators PPARG, PPARA, PPARD LMNA 2523/4885PPARA 2/4885PPARG 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.